65,437 trials
Parkinson Disease
Primary: Change in the Ratio of the Specific Striatal [123I]B-CIT Uptake to the Nondisplaceable Striatal [123I]B-CIT Uptake Between the Two Images — -2.6; -4.7; -3.7; -6.9…
High-grade Glioma · Lung Cancer · Head & Neck Cancer
Primary: Correlation of the Magnitude of [18F]Fluciclatide Uptake and Retention With Quantitative Measurement of the Levels of αvβ3 (Beta-3 Integrin) Integrin Expression in…
Asthma
Primary: FEV1 peak0-3 Change From Baseline — 0.373; 0.507; 0.547 Litres — p=0.0085
Congenital Disorder
Primary: Feasibility of Pacemaker Implant With Total Thoracoscopic Approach to Epicardial Pacing Lead — 100 percentage of particiapants
Pre-eclampsia
Primary: Change in Creatinine Clearance — -8; -22 milliliters/minute
Soft Tissue Sarcoma
Primary: Number of Participants With Enhanced T Lymphocyte Immune Response Specific for Soft Tissue Sarcoma Tumor Associated Antigens(STS-TAAs) — 2; 5 participants
Dry Eye
Primary: Mean Change in Fluorescein Staining Score From Baseline — -0.95; -1.34; -1.55 points — p=0.004
Pulmonary Disease, Chronic Obstructive
Primary: Number of Participants With Any Adverse Event (AE) or Any Serious Adverse Event (SAE) Throughout the Treatment Period — 105; 17 Participants
Diabetes Mellitus, Type 2
Primary: The Change From Baseline in Glycosylated Haemoglobin (HbA1c) After 104 Weeks of Treatment. — -0.66; -0.55 percentage of HbA1c — p=<0.0001
Colorectal Cancer
Primary: Progression-free Survival — 9.0; 12.6 Months
Major Depressive Disorder
Primary: Change From Baseline in the Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score at Week 10 — -14.76; -17.33; -17.58; -17.50 Units on a scale — p=0.0073
Relapsing Remitting Multiple Sclerosis
Primary: Change in Patient-reported Treatment Satisfaction — 22.69; 13.92 scores on a scale
Asthma
Primary: Comparison of the Maximum Percent Fall in FEV1 After Exercise Challenge at the End of the 2-week Treatment Period Between Arg/Arg and Gly/Gly Patients — 12.6; 16.5 %…
Breast Cancer
Primary: Pathological Complete Response Rates at Surgery — 16; 2 participants
Violence · Abuse
Primary: Change From Baseline to 3 Months Using the Recognition of Abusive Behavior Scale — 3.38; 3.37 mean scores